| Gene symbol | TERT | Synonyms | CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5p15.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | telomerase reverse transcriptase | ||||
| GTO ID | GTC1357 |
| Trial ID | NCT01153113 |
| Disease | Prostate Cancer |
| Altered gene | TERT |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | hTERT mRNA DC |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | Phase II Study of Active Immunotherapy With Mature, Human Telomerase Reverse Transcriptase Messenger RNA -Transfected, Autologous Dendritic Cells (DC) Administered In A Prime-Boost Format to Subjects With Metastatic Prostate Cancer |
| Year | 2008 |
| Country | United States |
| Company sponsor | University of Florida |
| Other ID(s) | LAMP hTERT DC Vaccine |
| Vector information | |||
|
|||
| Cohort1: dose level 1_dose level 2 | |||||||||
|
|||||||||
| Cohort2: dose level 1 | |||||||||
|
|||||||||